Consolidated Statements of Cash Flows (USD $)	9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011
Operating activities:
Net loss	$ (4,485,531)	$ (6,248,027)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	167,600	153,865
Change in valuation of derivative liabilities	0	36,745
Warrants issued for services	134,272	390,620
Stock-based compensation	655,124	1,066,733
Common stock issued for services	427,702	428,805
Amortization of loan discount	37,235	1,295,876
Amortization of loan discount - RHL	66,667	216,666
Loan commitment fee amortization	918	20,406
Subtotal - non-cash adjustments	1,489,518	3,609,716
Effect of changes in:
Accounts receivable	(139,643)	10,317
Inventory	41,726	78,285
Prepaid expenses and other current assets	132,959	83,437
Deposits	0	500
Accounts payable and accrued expenses	988,400	300,707
Related party payables	233,235	232,932
Compensation and severance payable	63,187	72,318
Deferred revenue	37,424	(98,548)
Subtotal - net change in operating assets and libilities	1,357,288	679,948
Net cash used in operating activities	(1,638,725)	(1,958,363)
Investing activities:
Purchase of property and equipment	(555)	(7,819)
Filing of patents (including biotech)	(206,386)	(155,327)
Cost of continuing MMRPro and website development	(61,995)	(252,932)
Net cash used in investing activities	(268,936)	(416,078)
Financing activities:
Net proceeds from convertible notes	781,995	1,259,751
Net proceeds from warrant exercises	59,500	328,280
Proceeds from equity line of credit	865,999	564,472
Proceeds from note payable	520,771	0
Payments of note payable	(399,100)	0
Proceeds from line of credit	15,000	0
Payments of line of credit	(204,895)	0
Proceeds from stock option exercises	0	45,503
Payments of capital lease	0	(6,269)
Net cash provided by financing activities	1,639,270	2,191,737
Net decrease in cash	(268,391)	(182,704)
Cash, beginning of period	311,103	363,689
Cash, end of period	42,712	180,985
Supplemental disclosures of cash flow information:
Cash paid for interest	80,576	19,341
Cash paid for income taxes	4,894	2,865
Supplemental disclosure of non-cash investing and financing activities:
Conversion of convertible notes into common stock	767,182	1,248,787
Payment of accounts payable and related party payables through issuance of common stock	373,214	1,213,083
Payment of payables through issuance of notes payable	0	24,387
Capitalized loan commitment fees payable	0	200,000
Establishment of derivative liabilities, net and reclassifcation back to APIC upon settlement	0	1,346,418
Prepayment for services through issuance of common stock	$ 0	$ 78,333